SECTION 1: INTRODUCTION 1

• Lecture1.1
  Review, Approval and Reimbursement Process

SECTION 2: OVERVIEW OF THE CANADIAN MARKET ACCESS LANDSCAPE 2

MODULE 1: Key Stakeholders in Market Access

• Lecture2.1
  Chapter 1: Roles and Responsibilities of Payer Stakeholders
• Lecture2.2
  Chapter 2: Value Proposition: Public Payers vs Prescribers

SECTION 2 (contd.): OVERVIEW OF THE CANADIAN MARKET ACCESS LANDSCAPE 3

Module 2: Overview of the Drug Reimbursement Review Process in Canada

• Lecture3.1
  Chapter 1: Review of the Overall Reimbursement Process
• Lecture3.2
  Chapter 2. CDR Review Process
• Lecture3.3
  Chapter 3: pCODR Review Process

SECTION 3: PUBLIC PAYER SUBMISSIONS FOR BRAND DRUG PRODUCTS 2

MODULE 1: Submissions

• Lecture4.1
  Chapter 1: Category 2 CDR Submissions
• Lecture4.2
  Chapter 2: pCODR Submissions

SECTION 3 (contd.): PUBLIC PAYER SUBMISSIONS FOR BRAND DRUG PRODUCTS 1

MODULE 2: Provincial Submission Process

• Lecture5.1
  Chapter 1: INESSS (Quebec)